Covey; Douglas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Covey; Douglas.The latest application filed is for "neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same".

Company Profile

4.11.20

Covey; Douglas - St. Louis MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Neuroactive 19-alkoxy-17-substituted Steroids, Prodrugs Thereof, And Methods Of Treatment Using Same App 20210308149 - Covey; Douglas ; et al.	2021-10-07
Neurosteroids And Enantiomers Thereof For The Prevention And Treatment Of Neurodegenerative Conditions App 20200246356 - Kind Code	2020-08-06
Neuroactive 19-alkoxy-17-substituted Steroids, Prodrugs Thereof, And Methods Of Treatment Using Same App 20200113916 - Covey; Douglas ; et al.	2020-04-16
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same Grant 10,342,809 - Covey , et al. July 9, 2	2019-07-09
Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors Grant 10,202,413 - Covey Feb	2019-02-12
Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors Grant 10,160,783 - Covey , et al. Dec	2018-12-25
Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors Grant 10,160,738 - Covey Dec	2018-12-25
NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS App 20180086727 - Covey; Douglas	2018-03-29
Neuroactive 13, 17-substituted Steroids As Modulators For Gaba Type-a Receptors App 20170355728 - Covey; Douglas ; et al.	2017-12-14
NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS App 20170233356 - Covey; Douglas	2017-08-17
Neuroactive 19-alkoxy-17-substituted Steroids, Prodrugs Thereof, And Methods Of Treatment Using Same App 20170232006 - Covey; Douglas ; et al.	2017-08-17
Neuroactive 19-alkoxy-17-substituted Steroids, Prodrugs Thereof, And Methods Of Treatment Using Same App 20170190732 - Covey; Douglas ; et al.	2017-07-06
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same Grant 9,676,812 - Covey , et al. June 13, 2	2017-06-13
Neuroactive 19-alkoxy-17-substituted Steroids, Prodrugs Thereof, And Methods Of Treatment Using Same App 20170152282 - Covey; Douglas ; et al.	2017-06-01
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same Grant 9,630,986 - Covey , et al. April 25, 2	2017-04-25
Neuroactive 13, 17-substituted Steroids As Modulators For Gaba Type-a Receptors App 20170037079 - Covey; Douglas ; et al.	2017-02-09
Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors Grant 9,562,026 - Covey February 7, 2	2017-02-07
Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors Grant 9,512,170 - Covey , et al. December 6, 2	2016-12-06
NEUROACTIVE SUBSTITUTED CYCLOPENTA[b]PHENANTHRENES AS MODULATORS FOR GABA TYPE-A RECEPTORS App 20160326127 - Covey; Douglas	2016-11-10
Neuroactive Enantiomeric 15-, 16- And 17-substituted Steroids As Modulators For Gaba Type-a Receptors App 20160251391 - Covey; Douglas	2016-09-01
Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same Grant 9,388,210 - Covey , et al. July 12, 2	2016-07-12
Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors Grant 9,365,502 - Covey June 14, 2	2016-06-14
Neuroactive Enantiomeric 15-, 16- And 17-substituted Steroids As Modulators For Gaba Type-a Receptors App 20150361125 - Covey; Douglas	2015-12-17
Neuroactive 19-alkoxy-17-substituted Steroids, Prodrugs Thereof, And Methods Of Treatment Using Same App 20150315230 - Covey; Douglas ; et al.	2015-11-05
Neuroactive 17(20)-z-vinylcyano-substituted Steroids, Prodrugs Thereof, And Methods Of Treatment Using Same App 20140309443 - Covey; Douglas ; et al.	2014-10-16
NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS App 20140275241 - Covey; Douglas	2014-09-18
NEUROACTIVE SUBSTITUTED CYCLOPENTA[b]PHENANTHRENES AS MODULATORS FOR GABA TYPE-A RECEPTORS App 20140256805 - Covey; Douglas	2014-09-11
Neuroactive 13, 17-substituted Steroids As Modulators For Gaba Type-a Receptors App 20140249120 - Covey; Douglas ; et al.	2014-09-04
Neuroactive 19-alkoxy-17-substituted Steroids, Prodrugs Thereof, And Methods Of Treatment Using Same App 20140235600 - Covey; Douglas ; et al.	2014-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.